Evaluation of nintedanib as a new postoperative antiscarring agent in experimental extraocular muscle surgery.

Bicaklioglu, Gozde; Pirhan, Dilara; Yazir, Yusufhan; Duruksu, Gokhan; Furat Rencber, Selenay; Yuksel, Nursen

Bicaklioglu, Gozde; Pirhan, Dilara; Yazir, Yusufhan; Duruksu, Gokhan; Furat Rencber, Selenay; Yuksel, Nursen.

Afiliação

Bicaklioglu G; Department of Ophthalmology, University of Health Sciences Trabzon Kanuni Training and Research Hospital, Trabzon 61250, Turkey.
Pirhan D; Department of Ophthalmology, Kocaeli University, Faculty of Medicine, Kocaeli 41380, Turkey.
Yazir Y; Stem Cell and Gene Therapy Research and Application Center, Kocaeli University, Kocaeli 41380, Turkey.
Duruksu G; Department of Histology and Embryology, Kocaeli University, Faculty of Medicine, Kocaeli 41380, Turkey.
Furat Rencber S; Stem Cell and Gene Therapy Research and Application Center, Kocaeli University, Kocaeli 41380, Turkey.
Yuksel N; Department of Histology and Embryology, Kocaeli University, Faculty of Medicine, Kocaeli 41380, Turkey.

Int J Ophthalmol ; 15(6): 914-923, 2022.

Article em En | MEDLINE | ID: mdl-35814898

Palavras-chave

extraocular muscle surgery; fibrosis; inflammation; nintedanib; triamcinolone acetonide

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Int J Ophthalmol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Turquia País de publicação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google